Orlando, FLNCT07293689Now EnrollingIRB Ready

Type III Achalasia Clinical Trial in Orlando, FL

Access cutting-edge type iii achalasia treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.

Sponsored by Northwestern University

Quick Self-Assessment

See if you qualify for this Orlando location

Preparing your pre-screening questions…

Expert Care in Orlando

Access type iii achalasia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type iii achalasia treatment provided free

Apply for This Orlando Location

Check if you qualify for this type iii achalasia clinical trial in Orlando, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Orlando

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Orlando site if eligible
  4. 4Begin participation

About This Type III Achalasia Study in Orlando

The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing due to certain conditions. The main question it aims to answer is: does pre-POEM testing help the physician choose how long to cut the muscle. Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

Sponsor: Northwestern University

Who Can Participate

Inclusion Criteria

Type III achalasia or EGJOO with spastic/hypercontractile features or Jackhammer Esophagus or Distal Esophageal Spasm
Eckardt Score \> 3

Exclusion Criteria

Prior surgical treatment for achalasia
Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
Known secondary achalasia related to malignancy (pseudoachalasia)
Known eosinophilic esophagitis
Diverticulum (\> 2 cm) in distal esophagus
Megaesophagus
Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
Standard contraindications to general anesthesia
Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
Unwillingness or inability to consent for the study
Anticipated inability to follow protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Orlando?

Yes, this clinical trial (NCT07293689) has an active research site in Orlando, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type III Achalasia Treatment Options in Orlando, FL

If you're searching for type iii achalasia treatment options in Orlando, FL, this clinical trial (NCT07293689) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type iii achalasia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type iii achalasia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Orlando, FL

See all pulmonary embolism clinical trials recruiting in Orlando — not just this study.

Browse Pulmonary Embolism Trials in Orlando

Ready to Join in Orlando?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Orlando, FL